Marc Goodman
Stock Analyst at Leerink Partners
(4.86)
# 356
Out of 4,455 analysts
842
Total ratings
56.3%
Success rate
18.4%
Average return
Main Sectors:
Stocks Rated by Marc Goodman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics | Initiated Coverage: Buy | $52 | $40.06 | +29.81% | 1 | Jun 24, 2026 | |
| STOK Stoke Therapeutics | Maintained: Buy | n/a | $32.00 | - | 11 | Jun 2, 2026 | |
| SPTX Seaport Therapeutics | Initiated Coverage: Buy | $35 | $21.40 | +63.55% | 1 | May 27, 2026 | |
| ACIU AC Immune | Maintained: Buy | n/a | $2.56 | - | 38 | Apr 7, 2026 | |
| ALKS Alkermes | Maintained: Hold | n/a | $55.08 | - | 45 | Mar 31, 2026 | |
| SGP SpyGlass Pharma | Initiated Coverage: Buy | $42 | $21.18 | +98.30% | 1 | Mar 3, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $75 | $126.89 | -40.89% | 1 | Mar 2, 2026 | |
| NMRA Neumora Therapeutics | Initiated Coverage: Buy | $8 | $1.64 | +387.80% | 1 | Jan 11, 2026 | |
| BHVN Biohaven | Maintained: Buy | $50 → $15 | $15.83 | -5.24% | 26 | Dec 25, 2025 | |
| MPLT MapLight Therapeutics | Initiated Coverage: Buy | $30 | $33.28 | -9.86% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $2.55 | +96.08% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $148.73 | -42.85% | 13 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $12.00 | +316.67% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $30 | $25.32 | +18.48% | 46 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $216.03 | - | 58 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $215 | $230.02 | -6.53% | 54 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.74 | - | 31 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $241.67 | - | 52 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.13 | - | 42 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $17.79 | +12.42% | 34 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $31.92 | +6.52% | 1 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $168.52 | - | 48 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $4.32 | +362.96% | 4 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $25.57 | +56.43% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.83 | +446.45% | 40 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $44.95 | -55.51% | 6 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $5.82 | +518.56% | 11 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.69 | n/a | 33 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.0221 | n/a | 9 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $254.66 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $13.08 | n/a | 17 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $2.13 | n/a | 1 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $74.78 | n/a | 10 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $70 | $0.8159 | n/a | 12 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $4.24 | n/a | 2 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $53.71 | n/a | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $136.01 | n/a | 1 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.01 | n/a | 1 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $215.75 | n/a | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $491.34 | n/a | 2 | Mar 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $473 | $632.90 | n/a | 1 | Nov 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $72 → $57 | $57.52 | n/a | 17 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $54 | $16.33 | n/a | 8 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $24.29 | n/a | 15 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $20 | $33.21 | n/a | 26 | Dec 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $128.66 | n/a | 16 | Oct 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $253.35 | n/a | 14 | Oct 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $98 | $9.95 | n/a | 8 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $85 | $1,208.12 | n/a | 12 | Jul 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $12 | $17.23 | n/a | 8 | Nov 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $118 | $127.88 | n/a | 3 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 | $4.13 | n/a | 3 | Jun 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $6.77 | n/a | 24 | Mar 21, 2016 |
Rapport Therapeutics
Jun 24, 2026
Initiated Coverage: Buy
Price Target: $52
Current: $40.06
Upside: +29.81%
Stoke Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $32.00
Upside: -
Seaport Therapeutics
May 27, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $21.40
Upside: +63.55%
AC Immune
Apr 7, 2026
Maintained: Buy
Price Target: n/a
Current: $2.56
Upside: -
Alkermes
Mar 31, 2026
Maintained: Hold
Price Target: n/a
Current: $55.08
Upside: -
SpyGlass Pharma
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $21.18
Upside: +98.30%
Veradermics
Mar 2, 2026
Initiated Coverage: Buy
Price Target: $75
Current: $126.89
Upside: -40.89%
Neumora Therapeutics
Jan 11, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.64
Upside: +387.80%
Biohaven
Dec 25, 2025
Maintained: Buy
Price Target: $50 → $15
Current: $15.83
Upside: -5.24%
MapLight Therapeutics
Nov 21, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $33.28
Upside: -9.86%
Nov 17, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $2.55
Upside: +96.08%
Oct 15, 2025
Reiterated: Buy
Price Target: $85
Current: $148.73
Upside: -42.85%
Oct 9, 2025
Reiterated: Buy
Price Target: $50
Current: $12.00
Upside: +316.67%
Oct 7, 2025
Maintained: Buy
Price Target: $32 → $30
Current: $25.32
Upside: +18.48%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $216.03
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $215
Current: $230.02
Upside: -6.53%
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $59.74
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $241.67
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: n/a
Current: $7.13
Upside: -
Oct 7, 2025
Maintained: Buy
Price Target: $10 → $20
Current: $17.79
Upside: +12.42%
Oct 6, 2025
Initiated Coverage: Buy
Price Target: $34
Current: $31.92
Upside: +6.52%
Sep 23, 2025
Maintained: Buy
Price Target: n/a
Current: $168.52
Upside: -
Sep 16, 2025
Reiterated: Buy
Price Target: $20
Current: $4.32
Upside: +362.96%
Aug 13, 2025
Maintained: Buy
Price Target: $40
Current: $25.57
Upside: +56.43%
Aug 12, 2025
Maintained: Buy
Price Target: $10
Current: $1.83
Upside: +446.45%
Aug 1, 2025
Reiterated: Buy
Price Target: $20
Current: $44.95
Upside: -55.51%
Aug 1, 2025
Maintained: Buy
Price Target: $36
Current: $5.82
Upside: +518.56%
May 13, 2025
Maintained: Hold
Price Target: n/a
Current: $6.69
Upside: n/a
Mar 26, 2025
Downgraded: Hold
Price Target: $1
Current: $0.0221
Upside: n/a
Jan 13, 2025
Maintained: Buy
Price Target: n/a
Current: $254.66
Upside: n/a
May 12, 2023
Maintained: Buy
Price Target: $4
Current: $13.08
Upside: n/a
Jan 24, 2023
Initiated Coverage: Buy
Price Target: $24
Current: $2.13
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $20
Current: $74.78
Upside: n/a
Jul 11, 2022
Maintained: Hold
Price Target: $70
Current: $0.8159
Upside: n/a
Jun 27, 2022
Maintained: Hold
Price Target: n/a
Current: $4.24
Upside: n/a
May 3, 2022
Maintained: Buy
Price Target: n/a
Current: $53.71
Upside: n/a
May 13, 2021
Maintained: Buy
Price Target: $25
Current: $136.01
Upside: n/a
May 4, 2021
Reiterated: Buy
Price Target: n/a
Current: $33.01
Upside: n/a
Apr 5, 2021
Maintained: Buy
Price Target: $31
Current: $215.75
Upside: n/a
Mar 19, 2019
Downgraded: Hold
Price Target: n/a
Current: $491.34
Upside: n/a
Nov 12, 2018
Initiated Coverage: Buy
Price Target: $473
Current: $632.90
Upside: n/a
May 21, 2018
Downgraded: Hold
Price Target: $72 → $57
Current: $57.52
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $46 → $54
Current: $16.33
Upside: n/a
Jan 31, 2018
Maintained: Buy
Price Target: $42
Current: $24.29
Upside: n/a
Dec 18, 2017
Maintained: Hold
Price Target: $34 → $20
Current: $33.21
Upside: n/a
Oct 30, 2017
Maintained: Buy
Price Target: $67
Current: $128.66
Upside: n/a
Oct 13, 2017
Maintained: Hold
Price Target: $95
Current: $253.35
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $110 → $98
Current: $9.95
Upside: n/a
Jul 26, 2017
Maintained: Hold
Price Target: $85
Current: $1,208.12
Upside: n/a
Nov 10, 2016
Reiterated: Sell
Price Target: $28 → $12
Current: $17.23
Upside: n/a
Nov 2, 2016
Maintained: Buy
Price Target: $118
Current: $127.88
Upside: n/a
Jun 14, 2016
Maintained: Sell
Price Target: $8
Current: $4.13
Upside: n/a
Mar 21, 2016
Rated: Buy
Price Target: n/a
Current: $6.77
Upside: n/a